Related Experiment Video
Updated: May 15, 2026
06:09
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Vemurafenib induces senescence features in melanoma cells
Sebastian Haferkamp1, Andreas Borst, Christian Adam
1Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
The Journal of Investigative Dermatology
|January 17, 2013
Summary
BRAF inhibitors like Vemurafenib can induce melanoma cell senescence, not just apoptosis. This stress-induced senescence may explain why melanoma tumors often return after treatment, impacting treatment durability.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Melanoma frequently harbors BRAF mutations, leading to pathway dependence.
- BRAF inhibitors, such as Vemurafenib, target this pathway, showing initial efficacy.
- Tumor relapse and incomplete apoptosis limit BRAF inhibitor effectiveness.
Purpose of the Study:
- To investigate the cellular response of melanoma to BRAF inhibition beyond apoptosis.
- To characterize the senescence phenotype induced by BRAF inhibition.
- To explore the in vivo relevance of BRAF inhibitor-induced senescence.
Main Methods:
- Utilized a large panel of melanoma cell lines.
- Assessed apoptosis and senescence markers (heterochromatin, cell shape, β-galactosidase activity).
- Xenografted human melanoma cells into nude mice for in vivo validation.
Main Results:
- Vemurafenib induced stress-induced senescence features in melanoma cells, alongside apoptosis.
- Senescence was characterized by heterochromatin formation, altered cell morphology, and increased β-galactosidase activity.
- Senescence markers were observed in xenografted human melanoma cells following BRAF(V600E) inhibition.
Conclusions:
- BRAF inhibition by Vemurafenib triggers a senescence response in melanoma cells.
- This senescence may contribute to incomplete apoptosis and tumor relapse.
- Understanding senescence is crucial for improving BRAF inhibitor efficacy and durability in melanoma treatment.
Related Concept Videos
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...